Research Topics
| V MenonSummaryAffiliation: Tufts-New England Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Long-term outcomes in nondiabetic chronic kidney diseaseV Menon
Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts, USA
Kidney Int 73:1310-5. 2008..In such patients, the primary emphasis should be on delaying progression of kidney disease...
Adiponectin and mortality in patients with chronic kidney diseaseVandana Menon
Tufts New England Medical Center, Division of Nephrology, 750 Washington Street, NEMC 391, Boston, MA 02111, USA
J Am Soc Nephrol 17:2599-606. 2006..Further studies are necessary to confirm this association and to elucidate the underlying mechanisms...- Factors associated with serum leptin in patients with chronic kidney diseaseV Menon
Department of Medicine, Division of Clinical Care Research, Tufts-New England Medical Center, Boston, MA, USA
Clin Nephrol 61:163-9. 2004..However, there is a stronger association between serum leptin and indices of body fat and gender in patients in the earlier stages of chronic kidney disease. 50% of the variability remains unexplained in patients with reduced GFR... - Body mass index and mortality in CKDMagdalena Madero
Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 50:404-11. 2007..Data are limited on the relationship of BMI with mortality in patients in the earlier stages of chronic kidney disease (CKD)... 
Role of adipose tissue in determining muscle mass in patients with chronic kidney diseaseCarmen Castaneda-Sceppa
Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111, USA
J Ren Nutr 17:314-22. 2007..Arm muscle area was used as an indicator of muscle mass...- Cystatin C as a risk factor for outcomes in chronic kidney diseaseVandana Menon
Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Ann Intern Med 147:19-27. 2007.... - Relationship between homocysteine and mortality in chronic kidney diseaseVandana Menon
Division of Nephrology, Department of Medicine, Tufts-New England Medical Center, Boston, MA, USA
Circulation 113:1572-7. 2006..Prior studies demonstrating an association between tHcy and CVD risk may have inadequately adjusted for the confounding effects of kidney function... - Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney diseaseVandana Menon
Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, Massachusetts, USA
J Am Soc Nephrol 16:3411-7. 2005..43; P = 0.07). HbA(1c) is associated with increased mortality in nondiabetic kidney disease. Hyperglycemia may be a potential therapeutic target and HbA(1c) may be important as a risk stratification tool in this high-risk population... - Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney diseaseVandana Menon
Department of Medicine, Division of Clinical Care Research, Tufts-New England Medical Center, Boston, MA, USA
Am J Kidney Dis 42:44-52. 2003..CRP levels are independently associated with serum albumin level and CVD prevalence. Inflammation may be involved in the pathophysiological state of malnutrition and CVD in the earlier stages of predominantly nondiabetic kidney disease... - Relationship of phosphorus and calcium-phosphorus product with mortality in CKDVandana Menon
Division of Nephrology, Department of Medicine, Tufts-New England Medical Center, Boston, MA, USA
Am J Kidney Dis 46:455-63. 2005.... - Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitaminsVandana Menon
Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 67:1539-46. 2005..There is insufficient evidence to suggest that low tHcy is associated with poor nutritional status in the MDRD Study cohort. B vitamins and GFR, but not dietary protein, are the major determinants of tHcy in this patient population... - C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney diseaseVandana Menon
Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 68:766-72. 2005..High CRP, but not serum albumin, is a risk factor for cardiovascular mortality. These results suggest that high CRP and hypoalbuminemia provide prognostic information independent of each other in CKD... - The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: a high-risk combinationVandana Menon
Division of Nephrology, Tufts-New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 45:223-32. 2005 - Homocysteine lowering and cardiovascular disease risk: lost in translationJeremy Marcus
Department of Medicine, Division of Nephrology, Tufts New England Medical Centre, Boston, Massachusetts 02111, USA
Can J Cardiol 23:707-10. 2007..Several more interventional trials are ongoing, but the available data thus far do not support screening for or treatment of hyperhomocysteinemia... - Recent trends in hospital management practices and prognosis after acute myocardial infarction in patients with kidney diseaseVandana Menon
Department of Medicine, Division of Nephrology, Tufts University School of Medicine/New England Medical Center, Boston, Massachusetts, USA
Am J Cardiol 94:1290-3. 2004.... - Changes in metabolic profile among antiretroviral-naive patients initiating protease inhibitor versus non-protease inhibitor containing HAART regimensFehmida Visnegarwala
J Acquir Immune Defic Syndr 33:653-5. 2003 - Cardiovascular risk factors in chronic kidney diseaseVandana Menon
Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 68:1413-8. 2005
Research Grants
- Novel Cardiac Risk Factors & Endothelial Function in CKDVandana Menon; Fiscal Year: 2007..This award will provide Dr. Menon with the final training necessary for her to make the transition from trainee to principal investigator. ..